CIK 0001348362
- Non-accelerated filer
- Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 202000871
- Phone
- +1 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-20 | Baxter Nicholas W Director | Option exercise · Stock Options | −110,000 | $0.10 | $11K | 150,000 |
| 2019-08-15 | Quigley Brian W. Director | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2019-05-06 | Baxter Nicholas W Director | Grant or award · Stock Options | +150,000 | $0.99 | $149K | 260,000 |
| 2019-05-06 | McKechnie William Edward Director | Grant or award · Stock Options | +150,000 | $0.99 | $149K | 260,000 |
| 2019-04-05 | Baxter Nicholas W Director | Other disposition · Stock Options | −50,000 | $1.53 | $77K | 10,000 |
| 2019-04-05 | McKechnie William Edward Director | Other acquisition · Stock Options | +50,000 | $1.53 | $77K | 110,000 |
| 2019-04-05 | BUNKA CHRISTOPHER Chief Executive Officer | Other disposition · Stock Options | −550,000 | $0.10 | $55K | 700,000 |
| 2019-02-15 | Spissinger Allan Horst Chief Financial Officer | Option exercise | +50,000 | $0.37 | $19K | 119,116 |
| 2019-02-15 | Spissinger Allan Horst Chief Financial Officer | Option exercise · Stock Options | −50,000 | $0.37 | $19K | 650,000 |
| 2018-08-31 | DOCHERTY JOHN MARTIN President | Grant or award | +36,500 | $2.07 | $76K | 1,622,250 |
| 2018-08-31 | BUNKA CHRISTOPHER CEO | Grant or award | +32,500 | $2.07 | $67K | 7,126,304 |
| 2018-08-14 | BUNKA CHRISTOPHER CEO | Gift | −500,000 | 7,093,804 | ||
| 2018-08-03 | DOCHERTY JOHN MARTIN Director | Grant or award | +182,500 | $1.32 | $241K | 1,494,500 |
| 2018-08-03 | DOCHERTY JOHN MARTIN Director | Grant or award | +91,250 | $1.24 | $113K | 1,585,750 |
| 2018-08-03 | BUNKA CHRISTOPHER CEO | Grant or award | +81,250 | $1.24 | $101K | 7,593,804 |
| 2018-06-18 | BUNKA CHRISTOPHER CEO | Option exercise | +450,000 | $0.14 | $63K | 6,081,844 |
| 2018-06-18 | BUNKA CHRISTOPHER CEO | Option exercise | +247,500 | $0.09 | $22K | 7,512,554 |
| 2018-06-18 | BUNKA CHRISTOPHER CEO | Option exercise · Stock Options | −247,500 | $0.09 | $22K | 1,250,000 |
| 2018-06-18 | BUNKA CHRISTOPHER CEO | Option exercise · Warrants | −450,000 | $0.14 | $63K | 0 |
| 2018-05-31 | Baxter Nicholas W Director | Purchase · Options | +50,000 | 160,000 |
Page 7 of 21 · 416 trades